ELV vs HIMS vs OSCR Stock Comparison

Elevance Health, Hims & Hers Health and Oscar Health Prices as of Nov 16, 2026 Peers: Industry group
1 more company in this comparison (MOH) Create a free account to keep reading and compare up to 10 companies.
ELV Elevance Health, Inc.
$446.47 +4.3% 1M +37.0% 1Y
Market cap
$93.96B
P/E
18.3x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
2 wins
OSCR Oscar Health, Inc.
$31.34 -1.7% 1M +125.8% 1Y
Market cap
$9.27B
P/E
10.8x
Revenue (TTM)
$17.47B
Div. yield
–
Managed Care Healthcare
9 wins

Head to Head

11 decided of 12

Oscar Health leads on 9 of the 12 questions below (Oscar Health 9, Elevance Health 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionELVHIMSOSCRLeader
Larger companyMarket capitalisation $93.96B $4.13B $9.27B ELV
Cheaper on earningsLower P/E, profitable companies only 18.3x -21.7x 10.8x OSCR
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.3x — 12.8x OSCR
Faster revenue growthRevenue growth, trailing twelve months +3.6% +29.8% +54.8% OSCR
More profitableNet margin, trailing twelve months 2.5% -6.6% 4.9% OSCR
Better return on capitalReturn on invested capital 8.3% — 34.5% OSCR
Less leveragedLower net debt / EBITDA -0.5x — -0.7x OSCR
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +37.0% -49.8% +125.8% OSCR
Better 5-year returnAnnualised price return, 5 years +0.8%/yr +18.0%/yr +21.8%/yr OSCR
Less volatileAnnualised volatility, 1 year 35.8% 91.2% 64.6% ELV
Higher overall scoreMean of the five percentile scores vs peers 68/100 38/100 77/100 OSCR

Percentile Scorecard

ELVHIMSOSCR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELVHIMSOSCR
Valuation 81 #6 of 27 36 #64 of 99 96 #2 of 27
Growth 36 #17 of 26 24 #68 of 89 100 #1 of 26
Profitability 72 #8 of 26 33 #62 of 92 100 #1 of 26
Financial Health 68 #9 of 26 20 #83 of 103 76 #7 of 26
Shareholder Returns 82 #4 of 18 76 #16 of 63 12 #16 of 18
Overall 68 38 77
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • HIMS ranked among 103 companies in Healthcare Providers
  • OSCR ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELVHIMSOSCRSPY
1 month +4.3%-33.9%-1.7% -3.0%
3 months +14.4%-35.2%-0.7% -4.2%
6 months +13.3%-16.7%+23.9% +0.2%
Year to date +27.4%-42.8%+118.1% +8.5%
1 year +37.0%-49.8%+125.8% +10.1%
3 years -3.6%+148.5%+311.8% +64.1%
3 years, per year -1.2%+35.5%+60.3% +18.0%
5 years +3.9%+128.6%+168.1% +58.1%
5 years, per year +0.8%+18.0%+21.8% +9.6%
10 years +222.6%—— +239.6%
10 years, per year +12.4%—— +13.0%

Risk

MeasureELVHIMSOSCRSPY
Volatility, 1Y 35.8%91.2%64.6% 13.8%
Downside volatility, 1Y 38.2%86.9%55.8% 14.2%
Beta vs S&P 500, 1Y 0.252.591.36 1.00
Return / volatility, 1Y 1.03-0.551.95 0.74
Max drawdown, 5Y -51.2%-78.9%-81.6% -25.4%
From 52-week high 0.0%-53.6%-10.9% -5.0%
52-week high $446.47$40.02$35.19 $779.14
52-week low $280.74$14.52$10.85 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELVHIMSOSCR
P/E now vs peer median 18.1xmedian 25.2x -24.2xmedian 22.4x 11.2xmedian 25.2x
P/S now vs peer median 0.5xmedian 0.4x 1.6xmedian 1.3x 0.5xmedian 0.4x
EV/EBITDA now vs peer median 9.6xmedian 14.5x -33.4xmedian 14.2x 0.1xmedian 14.5x
P/FCF now vs peer median 14.3xmedian 16.5x 145.7xmedian 19.0x 2.1xmedian 16.5x
P/B now vs peer median 2.1xmedian 2.7x 13.0xmedian 2.6x 3.8xmedian 2.7x
PEG now vs peer median -7.75median 1.72 0.35median 0.84 0.21median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELVHIMSOSCR
Revenue $201.83B $2.87B $17.47B
Gross profit $53.35B $1.83B $3.59B
Operating income $7.70B -$232.48M $936.99M
Net income $5.13B -$190.81M $855.54M
Free cash flow $6.51B $31.68M $4.14B
R&D – $212.19M –
EPS (diluted) $23.62 $-0.82 $2.47
Cash & equivalents $10.35B $605.60M $4.47B
Total debt $30.76B – $432.41M
Shares (diluted) 217.60M 233.82M 346.46M
Enterprise value -$48.62B $1.25B -$17.56B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELVHIMSOSCR
P/E 18.1x -24.2x 11.2x
P/FCF 14.3x 145.7x 2.1x
P/Operating cash flow 12.2x 25.6x 2.0x
P/S 0.5x 1.6x 0.5x
P/B 2.1x 13.0x 3.8x
P/Tangible book 2.7x -110.0x 3.8x
EV/EBITDA 9.6x -33.4x 0.1x
EV/EBIT 11.4x -16.8x 1.6x
EV/Revenue 0.4x 1.4x 0.1x
EV/FCF 13.5x 123.2x 0.4x
EV/Operating cash flow 11.6x 21.7x 0.4x
PEG (3Y EPS CAGR) -7.75 0.35 0.21

Growth

14 metrics
MetricELVHIMSOSCR
Revenue growth (1Y) 3.6% 29.8% 54.8%
Revenue CAGR (3Y) 6.2% 53.6% 47.7%
Gross profit growth (1Y) 4.3% 10.4% 97.0%
Gross profit CAGR (3Y) 5.5% 41.7% 48.2%
Operating income growth (1Y) -9.2% -302.1% 545.5%
Operating income CAGR (3Y) -4.2% -78.8% 71.0%
Net income growth (1Y) -7.4% -242.6% 451.0%
Net income CAGR (3Y) -5.2% -74.8% 64.6%
EPS growth (1Y) -4.5% -251.7% 362.3%
EPS CAGR (3Y) -2.3% -68.7% 53.1%
Operating cash flow growth (1Y) 54.6% -44.6% 443.4%
Operating cash flow CAGR (3Y) -7.2% 59.0% 129.0%
Free cash flow growth (1Y) 72.9% -76.3% 463.0%
Free cash flow CAGR (3Y) -7.6% -3.1% 124.6%

Profitability

14 metrics
MetricELVHIMSOSCR
Gross margin 26.4% 63.8% 20.6%
EBITDA margin 4.6% -4.1% 61.8%
Operating margin 3.8% -8.1% 5.4%
Pretax margin 3.1% -7.7% 5.2%
Net margin 2.5% -6.6% 4.9%
FCF margin 3.2% 1.1% 23.7%
Operating cash flow margin 3.8% 6.3% 23.9%
Return on equity 11.4% -65.9% 40.0%
Return on assets 4.0% -6.2% 8.1%
Return on invested capital 8.3% – 34.5%
Return on capital employed 9.6% -10.8% 28.3%
Asset turnover 1.6x 0.8x 1.6x
Cash conversion (OCF / net income) 1.5x -0.9x 4.9x
Stock comp / revenue 0.1% 6.2% 0.4%

Financial Health

11 metrics
MetricELVHIMSOSCR
Debt / assets 24.1% – 4.3%
Debt / equity 0.7x – 0.2x
Net debt / EBITDA -0.5x – -0.7x
Debt / FCF 4.7x – 0.1x
Liabilities / assets 65.0% 90.0% 77.8%
Equity / assets 35.0% 10.0% 22.2%
Interest coverage 5.3x – 68.3x
Current ratio 1.5x 0.9x 1.1x
Quick ratio 1.2x 0.8x 1.1x
Cash ratio 0.8x 0.5x 1.0x
Altman Z-score 3.06 1.29 2.54

Shareholder Returns

7 metrics
MetricELVHIMSOSCR
Dividend yield 1.6% – –
Net buyback yield 2.2% 1.3% -0.6%
Shareholder yield 3.8% 1.3% -0.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELVHIMSOSCR
Forward P/E 14.3xFY2026 – 12.8xFY2026
EPS, next fiscal year $30.12FY2026 $-0.93FY2026 $2.42FY2026
EPS growth, next FY -0.6%FY2026 -282.4%FY2026 –
EPS growth, the year after +4.2% – +5.0%
Revenue, next fiscal year $211.92BFY2026 $3.28BFY2026 $20.07BFY2026
Revenue growth, next FY +7.3%FY2026 +39.8%FY2026 +75.0%FY2026
Revenue growth, the year after +0.0% +25.4% +1.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELVHIMSOSCR
Held by institutions 91.8% 69.3% 72.5%
Institutions holding 1,615 510 407
Change in shares held, QoQ +1.7% +4.4% +13.6%
Institutions buying 862 325 267
Institutions selling 542 130 103
Buyers to sellers 1.59 2.50 2.59

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ELVHIMSOSCR
ELV 1.00 0.01 0.40
HIMS 0.01 1.00 0.16
OSCR 0.40 0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ELV, HIMS and OSCR?

Elevance Health (ELV) is the largest by market capitalisation: Elevance Health (ELV) $93.96B, Hims & Hers Health (HIMS) $4.13B, Oscar Health (OSCR) $9.27B.

Which stock is cheaper, ELV, HIMS and OSCR?

Oscar Health (OSCR) trades on the lowest price-to-earnings ratio (Elevance Health (ELV) 18.3x, Hims & Hers Health (HIMS) -21.7x, Oscar Health (OSCR) 10.8x). On next year's consensus earnings, Oscar Health (OSCR) is cheapest (Elevance Health (ELV) 14.3x, Oscar Health (OSCR) 12.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Oscar Health (OSCR) grew revenue fastest over the trailing twelve months: Elevance Health (ELV) +3.6%, Hims & Hers Health (HIMS) +29.8%, Oscar Health (OSCR) +54.8%.

Which company is more profitable?

Oscar Health (OSCR) has the highest net margin (Elevance Health (ELV) 2.5%, Hims & Hers Health (HIMS) -6.6%, Oscar Health (OSCR) 4.9%). On return on invested capital, Oscar Health (OSCR) leads (Elevance Health (ELV) 8.3%, Oscar Health (OSCR) 34.5%).

Which stock has performed better?

Over the past year Oscar Health (OSCR) returned the most: Elevance Health (ELV) +37.0%, Hims & Hers Health (HIMS) -49.8%, Oscar Health (OSCR) +125.8%. Over five years, Oscar Health (OSCR) compounded fastest (Elevance Health (ELV) +0.8%/yr, Hims & Hers Health (HIMS) +18.0%/yr, Oscar Health (OSCR) +21.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Elevance Health (ELV) has been the steadiest (Elevance Health (ELV) 35.8%, Hims & Hers Health (HIMS) 91.2%, Oscar Health (OSCR) 64.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ELV, HIMS and OSCR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Oscar Health (OSCR) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.